$LFVN
Lifevantage Corporation Common Stock (Delaware)
XNAS•Health Care•Pharmaceutical Preparations
$6.05
▲+0.83%+$0.050
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateLifevantage Corporation Common Stock (Delaware)
XNAS•Health Care•Pharmaceutical Preparations
Why is LFVN up today? It is at $6.05 (+0.83%), and our scanner flagged it 2 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LFVN spikes, and full due diligence on LFVN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LFVN 2 times in the last 30 days. Create a free account to track $LFVN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on LFVN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LFVN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystCharter / Bylaw Change, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Oct 10, 2026 · 2 days agoAcross every filing on file, supply equal to 205.2% of the tradeable float is in play - 205.2% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
Active shelf on file — the company can issue new shares on demand (valid ~3 years)
About $75.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Moorehead Terrence Officer | Acquired (grant/award) | +193K 1.5% of company | added 63% | 502K | n/a | Oct 7, 26 |
Aure Carl Officer | Acquired (grant/award) | +36K 0.3% of company | added 23% | 192K | n/a | Oct 7, 26 |
Cunningham Kristen Officer | Acquired (grant/award) | +33K 0.3% of company | added 27% | 152K | n/a | Oct 7, 26 |
Cunningham Kristen Officer | Sold (automatic/other) | -637 | sold 0.5% | 120K | $4K at $6.24 | Oct 1, 26 |
Aure Carl Officer | Sold (automatic/other) | -460 | sold 0.3% | 156K | $3K at $6.24 | Oct 1, 26 |
Lewis Darwin Director | Bought (open market) | +976 | added 0.7% | 138K | $6K at $6.22 | Sep 15, 26 |
Cunningham Kristen Officer | Sold (automatic/other) | -9K 0.07% of company | sold 6.9% | 120K | $55K at $6.18 | Sep 14, 26 |
Cunningham Kristen Officer | Sold (automatic/other) | -100 | sold <0.1% | 129K | $641 at $6.41 | Sep 11, 26 |
Cunningham Kristen Officer | Sold (automatic/other) | -2K 0.02% of company | sold 1.7% | 129K | $14K at $6.37 | Sep 10, 26 |
Aure Carl Officer | Sold (automatic/other) | -2K 0.01% of company | sold 1.2% | 156K | $12K at $6.37 | Sep 10, 26 |
Moorehead Terrence Officer | Acquired (grant/award) | +309K 2.5% of company | n/a | 309K | n/a | Aug 6, 26 |
Neufeld Alissa Officer | Sold (automatic/other) | -1K 0.01% of company | sold 1.2% | 113K | $8K at $6.25 | Jul 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on LFVN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LFVN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
LFVN last traded at $6.05, up 0.83% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Lifevantage Corporation Common Stock (Delaware) (LFVN) is next expected to report earnings on Tuesday, November 3, 2026, about 22 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. LFVN currently has a dividend yield of about 3.33% ($0.20 per share per year). Dividend figures can change; this is not investment advice.
The LFVN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LFVN 2 times in the last 30 days.
LFVN (Lifevantage Corporation Common Stock (Delaware)) trades on XNAS, with a market cap of about $76M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LFVN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LFVN discussion
Sign in to ask a question or join the discussion.